𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Structure–retention relationship study of diastereomeric (Z)- and (E)-2-alkylidene-4-oxothiazolidines

✍ Scribed by Maja Natić; Rade Marković; Dušanka Milojković-Opsenica; Živoslav Tešić


Publisher
John Wiley and Sons
Year
2007
Tongue
English
Weight
558 KB
Volume
30
Category
Article
ISSN
1615-9306

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

Quantitative structure–retention relationship (QSRR) was developed for a series of the (Z)‐ and (E)‐2‐alkylidene‐4‐oxothiazolidine derivatives by the multiple linear regression (MLR) analysis. Full geometry optimization based on Austin Model 1 (AM1) semiempirical molecular orbital method was carried out and a set of physicochemical molecular descriptors was calculated from the optimized structures. In order to obtain useful experimental parameters, the lipophilic character of analytes was measured by RP‐TLC, and lipophilicity parameters were correlated with physicochemical structural descriptors. Statistically significant and physically meaningful structure–retention relationships were obtained.


📜 SIMILAR VOLUMES


Quantitative structure–retention relatio
✍ Dragana Dabić; Maja Natić; Zdravko Džambaski; Rade Marković; Dušanka Milojković- 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 215 KB

## Abstract A quantitative structure–retention relationship (QSRR) was built to investigate the relationship between the structural descriptors of 23 newly synthesized __N__‐substituted 2‐alkylidene‐4‐oxothiazolidines and their chromatographic retention. Retention was investigated by means of the r

1H NMR Dynamic study of thermal Z/E isom
✍ R. Marković; M. Baranac; N. Juranić; S. Macura; I. Cekić; D. Minić 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 414 KB

The rotational barriers between the configurational isomers of two structurally related push-pull 4-oxothiazolidines, differing in the number of exocyclic C@C bonds, have been determined by dynamic 1 H NMR spectroscopy. The equilibrium mixture of (5-ethoxycarbonylmethyl-4-oxothiazolidin-2-ylidene)-1